Immuneering Ownership & Insider Activity

Immuneering (IMRX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 6.9% of shares outstanding. Institutional investors hold 41.0%.

Shares Outstanding

64.697M

Shares Float

49.090M

Insider Shares Owned

4.475M

Insider % Owned

6.9%

Institutional Shares Held

26.543M

Institutional % Held

41.0%

Ownership Breakdown

Net Insider Activity by Month

Immuneering Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jun 23, 2026	Benjamin J Zeskind	PRESIDENT AND CEO	BUY	2.400K	$4.56	$11K
Jun 15, 2026	Brett Matthew Hall	CHIEF SCIENTIFIC OFFICER	BUY	6.035K	$4.15	$25K